BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pernet O, Yadav SS, An DS. Stem cell-based therapies for HIV/AIDS. Adv Drug Deliv Rev 2016;103:187-201. [PMID: 27151309 DOI: 10.1016/j.addr.2016.04.027] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Re G, Tang B, Kou J, Hong C, Kuang Y. Chimeric Antigen Receptor-Modified Immune Cells for Eradication of HIV Reservoirs. Infect Dis Immun 2022;2:253-262. [DOI: 10.1097/id9.0000000000000066] [Reference Citation Analysis]
2 Kandula UR, Wake AD. Promising Stem Cell therapy in the Management of HIV and AIDS: A Narrative Review. BTT 2022;Volume 16:89-105. [DOI: 10.2147/btt.s368152] [Reference Citation Analysis]
3 Mei Q, Wang W, Wu J, Gao Y. Advances in HIV Eradication Strategies. Infectious Microbes and Diseases 2022;4:64-70. [DOI: 10.1097/im9.0000000000000088] [Reference Citation Analysis]
4 Scheller SH, Rashad Y, Saleh FM, Willingham KA, Reilich A, Lin D, Izadpanah R, Alt EU, Braun SE. Biallelic, Selectable, Knock-in Targeting of CCR5 via CRISPR-Cas9 Mediated Homology Directed Repair Inhibits HIV-1 Replication. Front Immunol 2022;13:821190. [PMID: 35386712 DOI: 10.3389/fimmu.2022.821190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Soundararajan D, Ramana LN, Shankaran P, Krishnan UM. Nanoparticle-based strategies to target HIV-infected cells. Colloids Surf B Biointerfaces 2022;213:112405. [PMID: 35255375 DOI: 10.1016/j.colsurfb.2022.112405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chupradit K, Khamaikawin W, Sakkhachornphop S, Puaninta C, Torbett BE, Borwornpinyo S, Hongeng S, Wattanapanitch M, Tayapiwatana C. Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study. Int J Mol Sci 2022;23:2331. [PMID: 35216446 DOI: 10.3390/ijms23042331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Widjaya MA, Ju JC, Lee SD. CRISPR-Edited Stem Cell Transplantation for HIV-Related Gene Modification In Vivo: A Systematic Review. Stem Cell Rev Rep 2022. [PMID: 35169967 DOI: 10.1007/s12015-022-10345-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mohamed H, Gurrola T, Berman R, Collins M, Sariyer IK, Nonnemacher MR, Wigdahl B. Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy. Front Immunol 2022;12:816515. [DOI: 10.3389/fimmu.2021.816515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Pai A, Cao P, White EE, Hong B, Pailevanian T, Wang M, Badie B, Hajimiri A, Berlin JM. Dynamically Programmable Magnetic Fields for Controlled Movement of Cells Loaded with Iron Oxide Nanoparticles. ACS Appl Bio Mater 2020;3:4139-47. [PMID: 35025416 DOI: 10.1021/acsabm.0c00226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 Yu S, Ou Y, Xiao H, Li J, Adah D, Liu S, Zhao S, Qin L, Yao Y, Chen X. Experimental Treatment of SIV-Infected Macaques via Autograft of CCR5-Disrupted Hematopoietic Stem and Progenitor Cells. Mol Ther Methods Clin Dev 2020;17:520-31. [PMID: 32258215 DOI: 10.1016/j.omtm.2020.03.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 das Neves J. Novel Approaches for the Delivery of Anti-HIV Drugs-What Is New? Pharmaceutics 2019;11:E554. [PMID: 31661775 DOI: 10.3390/pharmaceutics11110554] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Pang KM, Castanotto D, Li H, Scherer L, Rossi JJ. Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy. Nucleic Acids Res 2018;46:e6. [PMID: 29077949 DOI: 10.1093/nar/gkx980] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
13 Sun W, Luo Z, Lee J, Kim HJ, Lee K, Tebon P, Feng Y, Dokmeci MR, Sengupta S, Khademhosseini A. Organ-on-a-Chip for Cancer and Immune Organs Modeling. Adv Healthc Mater 2019;8:e1801363. [PMID: 30605261 DOI: 10.1002/adhm.201801363] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 16.5] [Reference Citation Analysis]
14 Carrillo MA, Zhen A, Kitchen SG. The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer. Front Immunol 2018;9:746. [PMID: 29755454 DOI: 10.3389/fimmu.2018.00746] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
15 Yu S, Yao Y, Xiao H, Li J, Liu Q, Yang Y, Adah D, Lu J, Zhao S, Qin L, Chen X. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection. Human Gene Therapy 2018;29:51-67. [DOI: 10.1089/hum.2017.032] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 12.4] [Reference Citation Analysis]
16 Khamaikawin W, Shimizu S, Kamata M, Cortado R, Jung Y, Lam J, Wen J, Kim P, Xie Y, Kim S, Arokium H, Presson AP, Chen ISY, An DS. Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1. Mol Ther Methods Clin Dev 2018;9:23-32. [PMID: 29322065 DOI: 10.1016/j.omtm.2017.11.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
17 Schwartz C, Bouchat S, Marban C, Gautier V, Van Lint C, Rohr O, Le Douce V. On the way to find a cure: Purging latent HIV-1 reservoirs. Biochem Pharmacol 2017;146:10-22. [PMID: 28687465 DOI: 10.1016/j.bcp.2017.07.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
18 Singh A. Biomaterials innovation for next generation ex vivo immune tissue engineering. Biomaterials 2017;130:104-10. [DOI: 10.1016/j.biomaterials.2017.03.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
19 Zulfiqar HF, Javed A, Sumbal, Afroze B, Ali Q, Akbar K, Nadeem T, Rana MA, Nazar ZA, Nasir IA, Husnain T. HIV Diagnosis and Treatment through Advanced Technologies. Front Public Health 2017;5:32. [PMID: 28326304 DOI: 10.3389/fpubh.2017.00032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
20 Takahashi M, Han S, Scherer L, Yoon S, Rossi J. Current Progress and Future Prospects in Nucleic Acid Based Therapeutics. Comprehensive Medicinal Chemistry III. Elsevier; 2017. pp. 280-313. [DOI: 10.1016/b978-0-12-409547-2.12424-2] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Symonds G, Bartlett JS, Kiem HP, Tsie M, Breton L. Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population. AIDS Patient Care STDS 2016;30:545-50. [PMID: 27905841 DOI: 10.1089/apc.2016.0245] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
22 Powell AB, Williams K, Cruz CRY. Gene-modified, cell-based therapies—an overview. Cytotherapy 2016;18:1351-9. [DOI: 10.1016/j.jcyt.2016.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
23 Goodman MA, Moradi Manesh D, Malik P, Rothenberg ME. CRISPR/Cas9 in allergic and immunologic diseases. Expert Rev Clin Immunol 2017;13:5-9. [PMID: 27687572 DOI: 10.1080/1744666X.2017.1241711] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
24 Tarunina M, Hernandez D, Kronsteiner-Dobramysl B, Pratt P, Watson T, Hua P, Gullo F, van der Garde M, Zhang Y, Hook L, Choo Y, Watt SM. A Novel High-Throughput Screening Platform Reveals an Optimized Cytokine Formulation for Human Hematopoietic Progenitor Cell Expansion. Stem Cells Dev 2016;25:1709-20. [PMID: 27554619 DOI: 10.1089/scd.2016.0216] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
25 Neves JD, Sarmento B, Sosnik A. Editorial: Biomedical Engineering Approaches for HIV/AIDS Prophylaxis, Diagnostics and Therapy. Adv Drug Deliv Rev 2016;103:1-4. [PMID: 27378403 DOI: 10.1016/j.addr.2016.06.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]